| Year |
Citation |
Score |
| 2020 |
Mendes FR, Leclerc JL, Liu L, Kamat PK, Naziripour A, Hernandez D, Li C, Ahmad AS, Doré S. Effect of Experimental Ischemic Stroke and PGE2 EP1 Selective Antagonism in Alzheimer's Disease Mouse Models. Journal of Alzheimer's Disease : Jad. PMID 31985468 DOI: 10.3233/Jad-191069 |
0.373 |
|
| 2020 |
Chen G, Kamat PK, Ahmad AS, Doré S. Distinctive effect of anesthetics on the effect of limb remote ischemic postconditioning following ischemic stroke. Plos One. 15: e0227624. PMID 31945776 DOI: 10.1371/Journal.Pone.0227624 |
0.352 |
|
| 2019 |
Mendes FR, Leclerc JL, Liu L, Kamat P, Hernandez D, Naziripour A, Ahmad AS, Dore S. Abstract TP321: Role of PGE
2
EP1 Receptor Antagonist on Stroke Outcomes in Alzheimer Disease Mouse Models Stroke. 50. DOI: 10.1161/Str.50.Suppl_1.Tp321 |
0.36 |
|
| 2018 |
Kamat PK, Leclerc JL, Patel R, Doré S. Abstract WP102: Unique Role of CD163 and Haptoglobin in Transient Ischemic Stroke Stroke. 49. DOI: 10.1161/Str.49.Suppl_1.Wp102 |
0.333 |
|
| 2015 |
Kamat PK. Streptozotocin induced Alzheimer's disease like changes and the underlying neural degeneration and regeneration mechanism. Neural Regeneration Research. 10: 1050-2. PMID 26330820 DOI: 10.4103/1673-5374.160076 |
0.305 |
|
| 2015 |
Kamat PK, Kalani A, Rai S, Tota SK, Kumar A, Ahmad AS. Streptozotocin Intracerebroventricular-Induced Neurotoxicity and Brain Insulin Resistance: a Therapeutic Intervention for Treatment of Sporadic Alzheimer's Disease (sAD)-Like Pathology. Molecular Neurobiology. PMID 26298663 DOI: 10.1007/S12035-015-9384-Y |
0.319 |
|
| 2013 |
Kalani A, Kamat PK, Tyagi SC, Tyagi N. Synergy of homocysteine, MicroRNA, and epigenetics: A novel therapeutic approach for stroke Molecular Neurobiology. 48: 157-168. PMID 23430482 DOI: 10.1007/s12035-013-8421-y |
0.302 |
|
| Show low-probability matches. |